More importantly, high CPEB4 expression indicated a poorer survival in high-grade glioma patients (P < 0.01) (Figure 4B) while it showed no statistical significance in low-grade glioma patients (P = 0.899) (Figure 4C). This evidence concerns the gene CPEB4 and glioma.